Clark Capital Management Group, Inc. Amgen Inc Transaction History

Clark Capital Management Group, Inc.

$13.8 Billion
Q4 2024

A detailed history of Clark Capital Management Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 1,263 shares of AMGN stock, worth $367,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,263

Previous 122,603 98.97%

Holding current value

$367,735

Previous $39.5 Million 99.17%

% of portfolio

0.0%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $31.4 Million - $39.8 Million	-121,340 Reduced 98.97%	1,263 $329,000
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $730,755 - $796,891	2,362 Added 1.96%	122,603 $39.5 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $482,934 - $586,891	1,838 Added 1.55%	120,241 $37.6 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $24.3 Million - $29.4 Million	-90,535 Reduced 43.33%	118,403 $33.7 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $53.4 Million - $60.3 Million	208,938 New	208,938 $60.2 Million
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $15.5 Million - $18.5 Million	-71,755 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $796,636 - $885,925	-3,395 Reduced 4.52%	71,755 $18.2 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $242,119 - $297,113	-1,224 Reduced 1.6%	75,150 $17.7 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $5.2 Million - $6.89 Million	-28,524 Reduced 27.19%	76,374 $15.5 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $392,232 - $504,153	-2,073 Reduced 1.94%	104,898 $25.3 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $153,390 - $183,794	881 Added 0.83%	106,971 $20.7 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $1.13 Million - $1.32 Million	6,764 Added 6.81%	106,090 $19.6 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $14.2 Million - $16 Million	-78,721 Reduced 44.21%	99,326 $18.9 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $7.19 Million - $8.39 Million	-40,277 Reduced 18.45%	178,047 $34.7 Million
Q3 2018 May 08, 2019	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 0.05%	218,324 $45.3 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $8.15 Million - $9.19 Million	44,001 Added 25.23%	218,424 $45.3 Million
Q2 2018 May 08, 2019	SELL	$166.05 - $186.51 $33,542 - $37,675	-202 Reduced 0.12%	174,423 $32.2 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.14 Million - $2.4 Million	12,876 Added 7.96%	174,625 $32.2 Million
Q1 2018 May 08, 2019	SELL	$169.43 - $198.0 $6,099 - $7,128	-36 Reduced 0.02%	161,749 $27.6 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $7.74 Million - $9.04 Million	45,678 Added 39.34%	161,785 $27.6 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $4.16 Million - $4.64 Million	-24,621 Reduced 17.5%	116,107 $20.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $23.5 Million - $26.9 Million	140,728	140,728 $26.2 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.

Account

Clark Capital Management Group, Inc. Amgen Inc Transaction History